fbpx Skip to main content

Member's Profile

Turning Point Therapeutics

10628 Science Center Dr Ste 200
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2014
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Turning Point Therapeutics
Biotech Company
Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Our lead therapeutic project, TPX-0005 (Repotrectinib), is in clinical development (TRIDENT-1).
Related News
No related news posted by this Member